Počet záznamů: 1  

Nanomedicine and Drug Delivery

  1. 1.
    SYSNO ASEP0381465
    Druh ASEPM - Kapitola v monografii
    Zařazení RIVC - Kapitola v knize
    NázevPolymer-modified gene delivery vectors retargeted with recombinant proteins
    Tvůrce(i) Pola, Robert (UMCH-V) RID, ORCID
    Pechar, Michal (UMCH-V) RID, ORCID
    Ulbrich, Karel (UMCH-V) RID
    Carlisle, R. C. (GB)
    Willemsen, R. A. (NL)
    Seymour, L. W. (GB)
    Zdroj.dok.Nanomedicine and Drug Delivery, Volume 1. - Oakville : Apple Academic Press, 2012 / Sebastian M. ; Ninan N. ; Haghi A. K. - ISBN 978-1-926895-17-8
    Rozsah strans. 33-38
    Poč.str.6 s.
    Poč.str.knihy320
    Forma vydáníTištěná - P
    Jazyk dok.eng - angličtina
    Země vyd.CA - Kanada
    Klíč. slovabungarotoxin ; poly(ethylene glycol) ; prostate-specific membrane antigen
    Vědní obor RIVCD - Makromolekulární chemie
    CEPGA203/08/0543 GA ČR - Grantová agentura ČR
    1M0505 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    CEZAV0Z40500505 - UMCH-V (2005-2011)
    AnotaceWe have prepared and characterized a multivalent reactive N-(2-hydroxypropyl)methacrylamide copolymer (PHPMA) bearing bungarotoxin-binding peptide (BTXbp). The polymer was used for covalent surface modification of adenoviral vectors containing luciferase reporter gene (Ad). The peptide BTXbp is known to have extremely high binding affinity to bungarotoxin (BTX) –a protein strongly binding to acetylcholine receptors. A recombinant protein consisting of antiPSMA antibody scFv fragment and BTX binding site (BTX-scFv) was used for retargeting of the polymer-modified Ad to prostate-specific membrane antigen (PSMA) receptors. While the polymer-modified Ad exhibited approximately 100-fold lower infectivity than the naked virus (in terms of luciferase expression), the addition of BTX-scFv to the polymer-coated Ad led to about 10-fold restoration of luciferase expression in PSMA-positive LNCaP cells. No such increase of transduction activity was observed in PSMA-negative PC3 cells. We have shown that the presented PHPMA-BTXbp/BTX-scFv system can be used as a universal tool for a receptor-specific viral gene therapy.
    PracovištěÚstav makromolekulární chemie
    KontaktEva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358
    Rok sběru2013
    Elektronická adresahttp://www.appleacademicpress.com/title.php?id=9781926895178
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.